Skip to main content
. 2021 Jan 5;10(1):158. doi: 10.3390/jcm10010158

Table 1.

Baseline demographic and clinical characteristics among participants stratified by treatment.

Disease Status Radical Prostatectomy Radiotherapy Active Surveillance p
Number of subjects (n) 104 37 55
Number of assessments (n) 288 96 107
Age at diagnosis, mean (SD) years 65.3 (5.66) 71.7 (4.96) 71.4 (8.02) 0.001
Education, years, mean (SD) years 12.4 (4.51) 10.8 (4.32) 10.5 (5.10) 0.02
Incomes (per 104 NTD per month) 5.74 (5.95) 3.09 (2.99) 4.90 (5.75) 0.04
Employment, n (%)
Employed 50 (48) 10 (27) 16 (29) 0.02
Unemployed 54 (51) 27 (73) 39 (71)
Comorbidities, n (%)
Cardiovascular disease 18 (17) 8 (21) 8 (14) 0.68
Hypertension 35 (33) 12 (32) 21 (38) 0.81
Diabetes 26 (25) 6 (16) 8 (14) 0.23
Arthritis 8 (8) 7 (18) 7 (12) 0.16
Anxiety (first assessment) 15 (14) 6 (16) 4 (7) 0.34
Anxiety (later assessment) 32 (17) 9 (15) 8 (15) 0.89
Peptic ulcer 3 (3) 2 (5) 4 (7) 0.44
Risk group, n (%)
Low 19 (18) 5 (13) 19 (34) 0.02
Intermediate 47 (45) 8 (22) 17 (31)
High 38 (37) 24 (65) 19 (34)
Prostate size at diagnosis, mean (SD) mL 39.2 (19.2) 44.4 (24.9) 43.1 (24.0) 0.36
ADL score (1st assessment), mean (SD) 66.6 (39.1) 67.7 (39.8) 79.5 (34.8) 0.11
Domain score (1st assessment), mean (SD)
Physical 14.4 (2.02) 14.1 (2.26) 14.4 (2.43) 0.72
Psychology 12.8 (1.85) 12.5 (1.52) 12.6 (1.82) 0.66
Social 13.7 (2.30) 13.7 (2.85) 14.0 (2.60) 0.81
Environment 14.4 (1.95) 14.1 (2.26) 14.2 (2.19) 0.73

Anxiety included depression; ADL–Barthel Index for activities of daily living. Patients under observation were also included the active surveillance group.